4.7 Review

Human Gut Microbiota in Heart Failure: Trying to Unmask an Emerging Organ

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review

Yujuan Li et al.

Summary: Atherosclerosis is characterized by endothelial damage, lipid deposition, and chronic inflammation. Gut microbiota plays an important role in the occurrence and development of atherosclerosis by regulating host metabolism and immunity. Microbial metabolites also affect mitochondrial function, promoting low-grade inflammation. Herbal medicines can effectively improve gut microbiota and its metabolites, improve mitochondrial function, and inhibit atherosclerotic plaques.

FRONTIERS IN PHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

The Interaction of Gut Microbiota and Heart Failure with Preserved Ejection Fraction: From Mechanism to Potential Therapies

Wei Yu et al.

Summary: HFpEF is a disease without definitive and effective treatment, affecting more than 50% of HF patients. Gut microbiota (GMB) has been shown to be related to HFpEF. In HFpEF patients, the composition of GMB is significantly altered and tends towards dysbiosis. Metabolites of GMB mediate various pathophysiological mechanisms of HFpEF.

BIOMEDICINES (2023)

Article Geriatrics & Gerontology

Mediterranean diet, mental health, cognitive status, quality of life, and successful aging in southern Italian older adults

Justyna Godos et al.

Summary: Studies show that adhering to the Mediterranean diet is associated with better mental and cognitive health, quality of life, and successful aging in middle-age and older adults. The results of this study indicate that individuals who adhere to the Mediterranean diet are less likely to have cognitive impairment and depressive symptoms, and are more likely to have good quality of life, good sleep quality, and successful aging.

EXPERIMENTAL GERONTOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Gut Microbiome-Based Management of Patients With Heart Failure JACC Review Topic of the Week

Petra Mamic et al.

Summary: Despite therapeutic advances, chronic heart failure (HF) still poses significant risks. Precision medicine approaches, especially in understanding the role of gut microbiome dysregulation, have the potential to provide novel biomarkers, therapeutic targets, and improved disease risk stratification. Deeper insights into gut microbiome-host interactions may pave the way toward personalized HF care and improved clinical outcomes.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Review Nutrition & Dietetics

Effects of Diet and Exercise on Circadian Rhythm: Role of Gut Microbiota in Immune and Metabolic Systems

Yidan Cai et al.

Summary: There is a close relationship between the intestinal microbiota and the circadian rhythm, regulated by the central-biological-clock system and the peripheral-biological-clock system. The intestinal flora also exhibits rhythmic oscillation. Poor diet and sedentary lifestyle can lead to immune and metabolic diseases. Numerous studies have shown that through diet, including fasting, and exercise, the human body can be influenced in its immune regulation, energy metabolism, and expression of biological-clock genes via the intestinal microbiota as the vector, resulting in reduced disease incidence rates. This article mainly discusses the effects of diet and exercise on the intestinal flora, immune, and metabolic systems from the perspective of the circadian rhythm, providing a more effective approach to prevent immune and metabolic diseases by modulating the intestinal microbiota.

NUTRIENTS (2023)

Review Cell Biology

The Implication of the Gut Microbiome in Heart Failure

Vasile Valeriu Lupu et al.

Summary: Heart failure is a global health problem that significantly impacts both individuals and healthcare systems. The gut microbiota plays a crucial role in human physiology and metabolic homeostasis and can directly or indirectly affect one's health and disease through their metabolites. Recent studies have shown a link between the gut microbiota and cardiovascular system, particularly in the development of heart failure-associated dysbiosis. Understanding the interactions between the gut microbiome, heart failure, and associated risk factors is essential for optimizing therapeutic strategies and personalized treatment.

CELLS (2023)

Article Gastroenterology & Hepatology

Performance of Gut Microbiome as an Independent Diagnostic Tool for 20 Diseases: Cross-Cohort Validation of Machine-Learning Classifiers

Min Li et al.

Summary: Cross-cohort validation of gut microbiome-based machine-learning classifiers for 20 diseases was systematically evaluated. High predictive accuracies were obtained in intra-cohort validation using single-cohort classifiers (around 0.77 AUC), except for intestinal diseases (around 0.73 AUC) in cross-cohort validation. Combined-cohort classifiers trained on samples from multiple cohorts were then built to improve validation of non-intestinal diseases, and the required sample size to achieve >0.7 validation accuracies was estimated. Higher validation performance was observed for classifiers using metagenomic data compared to 16S amplicon data in intestinal diseases. Marker Similarity Index was used to quantify cross-cohort marker consistency and similar trends were observed. Overall, the results support the gut microbiome as an independent diagnostic tool for intestinal diseases and reveal strategies to improve cross-cohort performance based on identified determinants of consistent cross-cohort gut microbiome alterations.

GUT MICROBES (2023)

Review Biochemistry & Molecular Biology

The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine

Sara Mousa et al.

Summary: Trillions of diverse microbes in the gut have significant impacts on drug metabolism and can lead to variation in drug response. The gut microbiome encodes millions of unique genes, greatly expanding the traditional drug metabolic reactions that occur in the liver. Recent findings also suggest that drugs can shape the gut microbial community, making it difficult to predict drug-microbiota interactions. This review discusses the multidirectional interaction between the host, oral medications, and gut microbiota and explores the potential of personalized medicine in drug metabolism.

METABOLITES (2023)

Article Cardiac & Cardiovascular Systems

Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure

Kymberleigh A. Romano et al.

Summary: A study found that the gut microbiota-dependent metabolite PAGln is associated with the presence and severity of heart failure both clinically and mechanistically. The circulating levels of PAGln are dose-dependently correlated with heart failure presence and indices of severity. It was also found that PAGln directly promotes heart failure-related phenotypes. Modulating the gut microbiome and PAGln production may be a potential therapeutic target for heart failure.

CIRCULATION-HEART FAILURE (2023)

Review Medicine, General & Internal

Probiotic supplementation during antibiotic treatment is unjustified in maintaining the gut microbiome diversity: a systematic review and meta-analysis

Anna Julia Elias et al.

Summary: This study systematically reviewed and meta-analyzed the effects of concurrent probiotic supplementation on gut microbiome composition during antibiotic therapy. The results showed that probiotic supplementation did not have a significant impact on gut microbiome diversity indices during antibiotic therapy. However, the limited number of studies and low sample sizes are the main limitations of this study, and further research is needed to determine appropriate microbiome diversity indices and their clinical relevance.

BMC MEDICINE (2023)

Review Cardiac & Cardiovascular Systems

Inflammation and Heart Failure: Searching for the Enemy-Reaching the Entelechy

Ioannis Paraskevaidis et al.

Summary: The role of inflammation in the development and progression of heart failure (HF) is well recognized. High levels of pro-inflammatory and inflammatory markers are associated with adverse outcomes in HF patients. Inflammation is also closely related to neurohormonal activation, which is crucial in HF pathophysiology and management. However, clinical trials with anti-inflammatory agents have yielded inconclusive or contradictory results in improving outcomes for HF. This review aims to explore the reciprocal relationship between inflammation and HF and identify potential therapeutic targets such as inflammatory cells, soluble mediators, and related inflammatory pathways.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2023)

Article Cardiac & Cardiovascular Systems

Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers

Filippos Triposkiadis et al.

Summary: Chronic heart failure (HF) is rare in the young and common in the elderly. The causes of HF in the young are usually specific, such as adult congenital heart disease, cardiomyopathies, myocarditis, or cardiotoxicity. On the other hand, the mechanisms underlying HF development in the elderly have not been fully understood. It is proposed that in most elderly patients, HF is the consequence of cardiovascular aging accelerated by specific risk factors, such as hypertension, obesity, type 2 diabetes mellitus (T2DM), coronary artery disease (CAD), and valvular heart disease (VHD), which affect both the heart and the vasculature.

HEART FAILURE REVIEWS (2022)

Article Biochemistry & Molecular Biology

Microbiome and metabolome features of the cardiometabolic disease spectrum

Sebastien Fromentin et al.

Summary: This study investigates the alterations of the metabolome and microbiome from dysmetabolic conditions to ischemic heart disease (IHD). The findings suggest that major changes in the gut microbiome and metabolome may occur long before the clinical onset of IHD. Specific microbiome and metabolome features associated with IHD could better differentiate individuals with IHD from healthy individuals, indicating their pathophysiological relevance.

NATURE MEDICINE (2022)

Review Biochemistry & Molecular Biology

Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes

Teresa Salvatore et al.

Summary: T2DM triggers systemic metabolic and non-metabolic signals, with enlarged EAT serving as a risk factor for heart failure by promoting myocardial fibrosis and dysfunction through inflammation; drugs like metformin may potentially reduce EAT enlargement in diabetic patients.

BIOMOLECULES (2022)

Review Cardiac & Cardiovascular Systems

Trimethylamine N-Oxide in Heart Failure: A Meta-Analysis of Prognostic Value

Xingxing Li et al.

Summary: The present study aimed to explore the prognostic value of trimethylamine N-oxide (TMAO) in heart failure (HF). The results showed that elevated TMAO was correlated with major adverse cardiovascular events (MACEs) and all-cause mortality in HF patients. Therefore, elevated TMAO may serve as an adverse prognostic indicator in patients with HF.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

The Gut Axis Involvement in Heart Failure Focus on Trimethylamine N-oxide

Andrea Salzano et al.

CARDIOLOGY CLINICS (2022)

Article Gastroenterology & Hepatology

Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice

Tiphaine Le Roy et al.

Summary: The study found that the newly identified bacterium was detected in 62.7%-69.8% of the healthy population. In obese individuals with metabolic syndrome, the abundance of Dysosmobacter genus was negatively correlated with body mass index, fasting glucose, and glycated hemoglobin. In mice, supplementation with live D. welbionis J115T partially counteracted diet-induced obesity, fat mass gain, insulin resistance, and white adipose tissue inflammation.
Article Biochemistry & Molecular Biology

Short-Chain Fatty Acid Receptors and Cardiovascular Function

Anastasios Lymperopoulos et al.

Summary: The gut microbiome and its associated metabolism play a crucial role in human cardiovascular health and disease. Short-chain fatty acids (SCFAs), derived from gut microbiota-mediated fermentation of dietary fiber, act as ligands for FFA receptors (FFARs) and exert various effects in cells and tissues. FFAR2 and FFAR3 have been found to be integral in regulating cardiovascular functions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

Environmental factors shaping the gut microbiome in a Dutch population

R. Gacesa et al.

Summary: This study analyzed the gut microbiome of 8,208 individuals from the Netherlands and found that the microbiome is primarily shaped by the environment and cohabitation. Only about 6.6% of microbial taxa are heritable, while around 48.6% of taxa are significantly influenced by cohabitation. Additionally, the study identified numerous associations between the microbiome and health, diet, socioeconomic factors, and early-life and current exposome.

NATURE (2022)

Review Gastroenterology & Hepatology

Current and future colorectal cancer screening strategies

Aasma Shaukat et al.

Summary: This Review provides an overview of current CRC screening options worldwide, including colonoscopy and stool-based tests. It also highlights the key features of each modality and describes new screening tests under development.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Food Science & Technology

Dietary Fats and the Gut Microbiota: Their impacts on lipid-induced metabolic syndrome

Sanjay Basak et al.

Summary: Metabolic syndrome can lead to inflammation and cardiovascular diseases, and the intake and metabolism of fatty acids can impact its development. The quality and quantity of dietary fats can also influence the composition of gut microbiota, affecting an individual's metabolic health.

JOURNAL OF FUNCTIONAL FOODS (2022)

Review Physiology

The Role of Plasma Membrane Sodium/Hydrogen Exchangers in Gastrointestinal Functions: Proliferation and Differentiation, Fluid/Electrolyte Transport and Barrier Integrity

Katerina Nikolovska et al.

Summary: The five plasma membrane Na+/H+ exchanger isoforms in the gastrointestinal tract have distinct characteristics and play important roles in maintaining intestinal homeostasis and disease pathogenesis.

FRONTIERS IN PHYSIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure

Xiao Zong et al.

Summary: This study aimed to investigate the association between serum PAGIn and chronic heart failure. The results showed that elevated PAGIn levels were an independent risk factor for heart failure and were associated with a higher risk of cardiovascular death and renal dysfunction.

ESC HEART FAILURE (2022)

Review Biochemistry & Molecular Biology

Gut Microbiota Ecosystem Governance of Host Inflammation, Mitochondrial Respiration and Skeletal Homeostasis

Wei-Shiung Lian et al.

Summary: Osteoporosis and osteoarthritis are the leading causes of musculoskeletal dysfunction in older adults. Gut microbiota and metabolites play an important role in maintaining the homeostasis of cartilage and bone tissue. Modulating gut microbiota and supplementing microbiota-derived metabolites may help slow down the development of these skeletal disorders.

BIOMEDICINES (2022)

Article Cardiac & Cardiovascular Systems

Knowledge Mapping of the Links Between the Gut Microbiota and Heart Failure: A Scientometric Investigation (2006-2021)

Fei Mu et al.

Summary: This study provides an overview of the link between gut microbiota and heart failure, highlighting the research trends and hotspots in this field. The analysis shows a steady increase in publications and citations, with the United States being the most prolific country. The keywords related to gut microbiota, heart failure, and risk factors emerge as important themes, and new research focuses on trimethylamine N-oxide (TMAO), bile acid, blood pressure, hypertension, and fermentation. Strategies to improve gut microbiota hold promise as a novel approach to treat heart failure.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Microbiology

Gut-microbiome-based predictive model for ST-elevation myocardial infarction in young male patients

Mingchuan Liu et al.

Summary: In this study, a prediction model for ST-segment elevation myocardial infarction (STEMI) based on the gut microbiome and clinical parameters was constructed. The model has potential clinical application in predicting STEMI in young males.

FRONTIERS IN MICROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury

Chen Fang et al.

Summary: This study found that elevated levels of phenylacetylglutamine (PAGln) are associated with atrial fibrillation (AF) and may contribute to its pathogenesis by promoting oxidative stress and apoptosis in atrial myocytes.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome

Yoshinaga Kawano et al.

Summary: Intestinal microbes protect against obesity and metabolic syndrome by inducing commensal-specific Th17 cells. High-fat, high-sugar diet depletes Th17-inducing microbes and promotes metabolic disease, while recovery of commensal Th17 cells restores protection. Th17 cells regulate lipid absorption across the intestinal epithelium in an IL-17-dependent manner. Dietary sugar and the presence of Faecalibaculum rodentium displace Th17-inducing microbiota and contribute to the immuno-pathogenicity of sugar.
Review Biochemistry & Molecular Biology

The Physiological Function and Potential Role of the Ubiquitous Na+/H+ Exchanger Isoform 8 (NHE8): An Overview Data

Claudio Bernardazzi et al.

Summary: The Na+/H+ exchanger transporters (NHE) play a crucial role in various biological processes and are widely expressed in human tissues and organs. NHE1 and NHE3 are well-studied isoforms, but recent discoveries have highlighted the importance of NHE8 in the gastrointestinal tract. This review discusses the physiological function and potential role of NHE8, providing useful overviews for future studies on this multifaceted protein.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Nutrition & Dietetics

Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice

Shinnosuke Hata et al.

Summary: This study compared the effects of luseogliflozin and a low-carbohydrate diet on sarcopenic obesity. The results showed that luseogliflozin could prevent sarcopenic obesity by improving amino acid metabolism.

NUTRIENTS (2022)

Review Nutrition & Dietetics

The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia-A Narrative Review

Ida J. Malesza et al.

Summary: Iron is essential for life, but a lack of it can lead to iron deficiency anemia, affecting around 1.2 billion people worldwide. The main treatment for iron deficiency anemia is iron supplementation, but this can have various side effects. This review explores the physiological mechanisms of iron management and investigates the relationship between iron supplementation, inflammatory status, and changes in gut microbiota.

NUTRIENTS (2022)

Review Oncology

Targeting the gut microbiota for cancer therapy

Miriam R. Fernandes et al.

Summary: Growing evidence suggests that the gut microbiota plays a crucial role in influencing the effectiveness and toxicity of cancer therapy, particularly immunotherapy and its adverse effects. Recent advances in research have led to a better understanding of the specific microbial species and mechanisms involved.

NATURE REVIEWS CANCER (2022)

Article Gastroenterology & Hepatology

The Healthy Microbiome-What Is the Definition of a Healthy Gut Microbiome?

Fergus Shanahan et al.

Summary: Defining a healthy microbiome in different populations is crucial, but requires improved profiling technologies and understanding the variations and influences on the microbiome among apparently healthy individuals.

GASTROENTEROLOGY (2021)

Article Biochemistry & Molecular Biology

Machine learning applications in microbial ecology, human microbiome studies, and environmental monitoring

Ryan B. Ghannam et al.

Summary: Advances in nucleic acid sequencing technology have expanded our understanding of microbial diversity. Machine learning is a valuable tool for analyzing microbial community data and making predictions, but the interpretability of the models must be considered.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Infectious Diseases

The Effect of Probiotics Supplementation on Gut Microbiota After Helicobacter pylori Eradication: A Multicenter Randomized Controlled Trial

Bo Tang et al.

Summary: Probiotics supplementation may help to establish a beneficial gut microbiota profile after eradication therapy. Specific bacteria taxa are associated with the outcome of H. pylori eradication.

INFECTIOUS DISEASES AND THERAPY (2021)

Review Biochemistry & Molecular Biology

Microbial Regulation of Host Physiology by Short-chain Fatty Acids

Bart van der Hee et al.

Summary: The ancestral diet had more fiber, while modern society's diet lacks it. SCFAs produced by gut bacteria fermenting fiber play a crucial role in intestinal homeostasis and the pathophysiology of human diseases. SCFAs can also impact tissues and organs beyond the gut through blood circulation, inducing epigenetic changes in the genome.

TRENDS IN MICROBIOLOGY (2021)

Review Microbiology

Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment

Laura Judith Marcos-Zambrano et al.

Summary: The increasing number of microbiome-related studies has provided more data on human microbiome composition and function, allowing for deeper exploration of host-microbiome associations and their impact on complex diseases. Improved data-analytical tools are necessary to effectively utilize the peculiarities of microbiome data, while machine learning offers insights into personalized medicine and disease prediction. This review focuses on the application of machine learning in microbiome studies for diagnostics, prognostics, and therapeutics, highlighting the potential for using microbial communities to predict disease states and stratify patients.

FRONTIERS IN MICROBIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

Article Pediatrics

Impact of probiotics supplement on the gut microbiota in neonates with antibiotic exposure: an open-label single-center randomized parallel controlled study

Hui Zhong et al.

Summary: Antibiotic therapy has a significant impact on the gut microbiota of neonates, particularly in decreasing levels of Bifidobacterium and Lactobacillus. The concurrent use of probiotics with antibiotics is beneficial for the gut microbiota, especially in promoting the abundance of Bifidobacterium, compared to delaying probiotic use after antibiotic treatment.

WORLD JOURNAL OF PEDIATRICS (2021)

Review Nutrition & Dietetics

Effect of Diet and Dietary Components on the Composition of the Gut Microbiota

Ashley Beam et al.

Summary: This review explores the impact of different diets on the gut microbiota composition, finding that specific dietary components in plant-based and Mediterranean diets can influence microbial composition and bacterial metabolites, which in turn affect systemic inflammation and metabolic endotoxemia. These associations between diet/dietary components and altering bacterial composition may provide potential therapeutic targets for type II diabetes, obesity, and inflammatory diseases.

NUTRIENTS (2021)

Article Geriatrics & Gerontology

The PROMOTe study: targeting the gut microbiome with prebiotics to overcome age-related anabolic resistance: protocol for a double-blinded, randomised, placebo-controlled trial

Mary Ni Lochlainn et al.

Summary: This study aims to investigate the role of the gut microbiome in anabolic resistance to dietary protein in older adults by testing whether modulation of the gut microbiome using a prebiotic, in addition to protein supplementation, can improve muscle strength. The study is a randomised, double-blinded, placebo-controlled trial, with participants taking supplementation once daily for 12 weeks in addition to resistance exercises, with measures taken over video and questionnaires and cognitive testing conducted at the beginning and end of the study.

BMC GERIATRICS (2021)

Review Microbiology

Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs

Shukai Zhan et al.

Summary: The intestinal microbiota plays a crucial role in the causative and preventive effects of intestinal fibrosis, as well as in the relationships with fibrosis in other organs. Colonized microbes are associated with fibrosis through their structural components and metabolic products, potentially regulating inflammation, fibroblast activation, and extracellular matrix formation in different organs. The findings suggest that understanding the mechanisms by which intestinal microbiota regulate fibrotic processes in other organs could provide insights for studying prospective mechanisms in intestinal fibrosis.

FRONTIERS IN MICROBIOLOGY (2021)

Review Endocrinology & Metabolism

The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium

Valmore Bermudez et al.

Summary: This article discusses the pathophysiology and consequences of adipose tissue expansion, particularly its association with meta-inflammation and microbiota dysbiosis. It also explores the mechanisms involved in metabolic reprogramming in AT, which may be causative factors for cardiovascular disease. Finally, it clarifies how lifestyle changes can improve myocardial cell function and develop effective non-pharmacologic approaches to combating CVD through changes in AT proteomics and gut microbiome.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Medicine, General & Internal

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial

Ayodeji Awoyemi et al.

Summary: This study aimed to investigate the effects of Saccharomyces boulardii and rifaximin on LVEF and microbiota in HF patients. The results showed that three months of treatment did not significantly affect LVEF, microbiota diversity, or measured biomarkers.

EBIOMEDICINE (2021)

Review Microbiology

Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota

Noora Alhajri et al.

Summary: The intestinal microbial ecosystem plays a critical role in the development and prevention of cardiovascular diseases (CVDs) and other metabolic disorders. Imbalances in gut microbiota composition have been linked to the development of new CVDs, highlighting the importance of understanding the gut-host interaction for disease management.

MICROORGANISMS (2021)

Article Microbiology

Applying Machine Learning to Predict the Exportome of Bovine and Canine Babesia Species That Cause Babesiosis

Stephen J. Goodswen et al.

Summary: Infections from Babesia in red blood cells can lead to severe diseases in susceptible hosts. Bovine babesiosis and canine babesiosis are significant issues in the beef and dairy cattle industries, as well as with dogs. Machine learning methods have been developed to predict exportome members, providing valuable insights for laboratory validation.

PATHOGENS (2021)

Review Cardiac & Cardiovascular Systems

Short-Chain Carbon Sources Exploiting Pleiotropic Effects for Heart Failure Therapy

Azariyas A. Challa et al.

Summary: Heart failure remains a major cause of morbidity and mortality in developed countries, with recent studies suggesting that improved myocardial energetics could benefit patients. Ketone bodies and short-chain fatty acids, in addition to serving as alternative fuels, also have various non-metabolic functions that hold promise for treating HF patients.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Review Gastroenterology & Hepatology

Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases

Jing Xu et al.

Summary: Cardiovascular diseases (CVDs) remain a major global health concern, with recent evidence suggesting that alterations in the gut microbiome may influence the pathogenesis and progression of CVDs. The underlying links are not fully understood, but advances in meta-omics approaches offer a promising new avenue for research and potential insights into cardiovascular diseases.

GUT MICROBES (2021)

Article Medical Laboratory Technology

Trimethylamine N-Oxide is Associated with Heart Failure Risk in Patients with Preserved Ejection Fraction

Zengxiang Dong et al.

Summary: The level of TMAO is closely associated with the risk of HFpEF and is an independent risk factor in patients with HFpEF. TMAO is also correlated with BUN, creatinine, and NT-proBNP in HFpEF patients.

LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

Trimethylamine N-Oxide is Associated with Heart Failure Risk in Patients with Preserved Ejection Fraction

Zengxiang Dong et al.

Summary: The study confirmed significantly elevated plasma levels of TMAO in HFpEF patients compared to controls, and identified a relationship between TMAO and HFpEF risk.

LABORATORY MEDICINE (2021)

Review Gastroenterology & Hepatology

Harnessing machine learning for development of microbiome therapeutics

Laura E. McCoubrey et al.

Summary: Seminal microbiome research in the past twenty years has shown the intrinsic relationship between microbiota and human health, with imbalanced microbiomes linked to diseases. Machine learning offers powerful techniques for analyzing and predicting microbiome big data, facilitating the development of new therapeutics.

GUT MICROBES (2021)

Article Cell Biology

Microbial Metabolite Signaling Is Required for Systemic Iron Homeostasis

Nupur K. Das et al.

CELL METABOLISM (2020)

Review Biochemistry & Molecular Biology

Current nutritional and pharmacological anti-aging interventions

Manuel Ros et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association

Salim S. Virani et al.

CIRCULATION (2020)

Article Agriculture, Multidisciplinary

Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease

Ying-Ying Zheng et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)

Article Multidisciplinary Sciences

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota

Arnau Vich Vila et al.

NATURE COMMUNICATIONS (2020)

Review Medicine, General & Internal

Role of gut microbiota in type 2 diabetes pathophysiology

Manoj Gurung et al.

EBIOMEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

Cristiane C. K. Mayerhofer et al.

ESC HEART FAILURE (2020)

Article Biochemistry & Molecular Biology

A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors

Ina Nemet et al.

Article Gastroenterology & Hepatology

Microbiome-Based Biomarkers for IBD

Ashwin N. Ananthakrishnan

INFLAMMATORY BOWEL DISEASES (2020)

Review Cardiac & Cardiovascular Systems

Gut Microbiota and Cardiovascular Disease

Marco Witkowski et al.

CIRCULATION RESEARCH (2020)

Article Gastroenterology & Hepatology

Gut microbiome, big data and machine learning to promote precision medicine for cancer

Giovanni Cammarota et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Cell Biology

Sodium Butyrate-Modulated Mitochondrial Function in High-Insulin Induced HepG2 Cell Dysfunction

Tingting Zhao et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)

Article Multidisciplinary Sciences

Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)

Yifei Zhang et al.

NATURE COMMUNICATIONS (2020)

Article Geriatrics & Gerontology

Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke

Yi Ling et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Review Biochemistry & Molecular Biology

Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes

Teresa Vezza et al.

ANTIOXIDANTS (2020)

Article Computer Science, Artificial Intelligence

Database limitations for studying the human gut microbiome

Camila K. Dias et al.

PEERJ COMPUTER SCIENCE (2020)

Review Endocrinology & Metabolism

Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function

James Frampton et al.

NATURE METABOLISM (2020)

Article Infectious Diseases

Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome

Paul A. Cardenas et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)

Article Gastroenterology & Hepatology

Microbiome-Based Biomarkers for IBD

Ashwin N. Ananthakrishnan

INFLAMMATORY BOWEL DISEASES (2020)

Review Biochemical Research Methods

Proteomics and the microbiome: pitfalls and potential

Huafeng Lin et al.

EXPERT REVIEW OF PROTEOMICS (2019)

Review Biochemistry & Molecular Biology

Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer

Sally Temraz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Cardiac & Cardiovascular Systems

Gut Microbiome and Response to Cardiovascular Drugs

Sony Tuteja et al.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)

Article Medicine, Research & Experimental

Metabolic signature of obesity-associated insulin resistance and type 2 diabetes

Haya Al-Sulaiti et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF

Toru Suzuki et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Article Medicine, Research & Experimental

Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload

Andrew J. Schwartz et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Cardiac & Cardiovascular Systems

Dietary metabolism, the gut microbiome, and heart failure

W. H. Wilson Tang et al.

NATURE REVIEWS CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies

Inder S. Anand et al.

CIRCULATION (2018)

Letter Cardiac & Cardiovascular Systems

Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts

Martin Kummen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Food Science & Technology

The Effect of Different L-Carnitine Administration Routes on the Development of Atherosclerosis in ApoE Knockout Mice

Ying Zhao et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2018)

Review Biochemistry & Molecular Biology

Current understanding of the human microbiome

Jack A. Gilbert et al.

NATURE MEDICINE (2018)

Review Immunology

Microbiome and Allergic Diseases

Mariona Pascal et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Cardiac & Cardiovascular Systems

The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

Nazir Savji et al.

JACC-HEART FAILURE (2018)

Article Microbiology

Dynamics of metatranscription in the inflammatory bowel disease gut microbiome

Melanie Schirmer et al.

NATURE MICROBIOLOGY (2018)

Review Pharmacology & Pharmacy

Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation

Xiaomeng Ren et al.

CURRENT PHARMACEUTICAL DESIGN (2018)

Article Multidisciplinary Sciences

Extensive impact of non-antibiotic drugs on human gut bacteria

Lisa Maier et al.

NATURE (2018)

Review Medicine, Research & Experimental

Interaction between gut microbiome and cardiovascular disease

Jieting Peng et al.

LIFE SCIENCES (2018)

Meeting Abstract Cardiac & Cardiovascular Systems

QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg study

A. Andrea Pozzi et al.

EUROPEAN JOURNAL OF HEART FAILURE (2018)

Review Cardiac & Cardiovascular Systems

Role of gut microbiota in atherosclerosis

Annika Lindskog Jonsson et al.

NATURE REVIEWS CARDIOLOGY (2017)

Review Biochemistry & Molecular Biology

Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery

J. Mark Brown et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Article Cardiac & Cardiovascular Systems

Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure

Cristiane C. K. Mayerhofer et al.

JOURNAL OF CARDIAC FAILURE (2017)

Letter Cardiac & Cardiovascular Systems

Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction

Katharina Schuett et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Editorial Material Cardiac & Cardiovascular Systems

Association between the gut microbiome and atherosclerosis

William T. Barrington et al.

NATURE REVIEWS CARDIOLOGY (2017)

Review Genetics & Heredity

Human genetic variation and the gut microbiome in disease

Andrew Brantley Hall et al.

NATURE REVIEWS GENETICS (2017)

Review Multidisciplinary Sciences

Chemical transformation of xenobiotics by the human gut microbiota

Nitzan Koppel et al.

SCIENCE (2017)

Article Multidisciplinary Sciences

The gut microbiome in atherosclerotic cardiovascular disease

Zhuye Jie et al.

NATURE COMMUNICATIONS (2017)

Review Cardiac & Cardiovascular Systems

Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure

Takehiro Kamo et al.

KOREAN CIRCULATION JOURNAL (2017)

Review Gastroenterology & Hepatology

Pathophysiology of Intestinal Na+/H+ Exchange

Michael A. Gurney et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article History & Philosophy Of Science

The coupling of taxonomy and function in microbiomes

S. Andrew Inkpen et al.

BIOLOGY & PHILOSOPHY (2017)

Review Biochemistry & Molecular Biology

The Origin and Diversification of Mitochondria

Andrew J. Roger et al.

CURRENT BIOLOGY (2017)

Letter Cardiac & Cardiovascular Systems

Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects

Weifei Zhu et al.

CIRCULATION (2017)

Article Biochemistry & Molecular Biology

Mining the Human Gut Microbiota for Immunomodulatory Organisms

Naama Geva-Zatorsky et al.

Article Cardiac & Cardiovascular Systems

Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure

Chelsea L. Organ et al.

CIRCULATION-HEART FAILURE (2016)

Article Gastroenterology & Hepatology

Proton pump inhibitors affect the gut microbiome

Floris Imhann et al.

Article Gastroenterology & Hepatology

Proton pump inhibitors alter the composition of the gut microbiota

Matthew A. Jackson et al.

Review Geriatrics & Gerontology

Physical activity in older age: perspectives for healthy ageing and frailty

Jamie S. McPhee et al.

BIOGERONTOLOGY (2016)

Review Cardiac & Cardiovascular Systems

Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal

Olurotimi O. Mesubi et al.

CARDIOVASCULAR RESEARCH (2016)

Article Biochemistry & Molecular Biology

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

Weifei Zhu et al.

Article Cardiac & Cardiovascular Systems

Trimethylamine N-oxide and prognosis in acute heart failure

Toru Suzuki et al.

HEART (2016)

Article Multidisciplinary Sciences

Human gut microbes impact host serum metabolome and insulin sensitivity

Helle Krogh Pedersen et al.

NATURE (2016)

Review Multidisciplinary Sciences

Diet-microbiota interactions as moderators of human metabolism

Justin L. Sonnenburg et al.

NATURE (2016)

Review Medicine, General & Internal

The Human Intestinal Microbiome in Health and Disease

Susan V. Lynch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Multidisciplinary Sciences

Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity

Alexandra Zhernakova et al.

SCIENCE (2016)

Article Biochemical Research Methods

Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights

Edoardo Pasolli et al.

PLOS COMPUTATIONAL BIOLOGY (2016)

Article Immunology

Altered fecal microbiota composition in patients with major depressive disorder

Haiyin Jiang et al.

BRAIN BEHAVIOR AND IMMUNITY (2015)

Article Biochemistry & Molecular Biology

Personalized Nutrition by Prediction of Glycemic Responses

David Zeevi et al.

Article Multidisciplinary Sciences

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

Kristoffer Forslund et al.

NATURE (2015)

Article Medicine, General & Internal

A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010

Yariv Gerber et al.

JAMA INTERNAL MEDICINE (2015)

Article Biochemistry & Molecular Biology

Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation

Jill C. Gregory et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Human Genetics Shape the Gut Microbiome

Julia K. Goodrich et al.

Review Microbiology

Microbes, Microbiota, and Colon Cancer

Cynthia L. Sears et al.

CELL HOST & MICROBE (2014)

Article Cardiac & Cardiovascular Systems

Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat

Xiaohong Tracey Gan et al.

CIRCULATION-HEART FAILURE (2014)

Review Cardiac & Cardiovascular Systems

The heart and the gut

Gerhard Rogler et al.

EUROPEAN HEART JOURNAL (2014)

Article Cardiac & Cardiovascular Systems

Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion

Evelien E. S. van Riet et al.

EUROPEAN JOURNAL OF HEART FAILURE (2014)

Editorial Material Cardiac & Cardiovascular Systems

20 Things You Didn't Know About the Human Gut Microbiome

Erin P. Ferranti et al.

JOURNAL OF CARDIOVASCULAR NURSING (2014)

Article Cardiac & Cardiovascular Systems

Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure Refining the Gut Hypothesis

W. H. Wilson Tang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Review Urology & Nephrology

The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review

Raymond Vanholder et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Article Multidisciplinary Sciences

Diet rapidly and reproducibly alters the human gut microbiome

Lawrence A. David et al.

NATURE (2014)

Article Gastroenterology & Hepatology

Influence of a probiotic mixture on antibiotic induced microbiota disturbances

Sofia Forssten et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Biotechnology & Applied Microbiology

Host lifestyle affects human microbiota on daily timescales

Lawrence A. David et al.

GENOME BIOLOGY (2014)

Article Gastroenterology & Hepatology

A novel SCFA receptor, the microbiota, and blood pressure regulation

Jennifer L. Pluznick

GUT MICROBES (2014)

Review Biochemistry & Molecular Biology

The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

Gijs den Besten et al.

JOURNAL OF LIPID RESEARCH (2013)

Article Biochemistry & Molecular Biology

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

Robert A. Koeth et al.

NATURE MEDICINE (2013)

Article Medicine, General & Internal

Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk

W. H. Wilson Tang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Immunology

The Microbiome in Infectious Disease and Inflammation

Kenya Honda et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

Article Multidisciplinary Sciences

Gut microbiota composition correlates with diet and health in the elderly

Marcus J. Claesson et al.

NATURE (2012)

Article Biotechnology & Applied Microbiology

Unlocking the potential of metagenomics through replicated experimental design

Rob Knight et al.

NATURE BIOTECHNOLOGY (2012)

Review Cell Biology

Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR

Anna C. Calkin et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)

Review Gastroenterology & Hepatology

Microbes-induced EMT at the crossroad of inflammation and cancer

Paul Hofman et al.

GUT MICROBES (2012)

Review Cardiac & Cardiovascular Systems

Multiple Facets of NF-κB in the Heart To Be or Not to NF-κB

Joseph W. Gordon et al.

CIRCULATION RESEARCH (2011)

Article Multidisciplinary Sciences

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Zeneng Wang et al.

NATURE (2011)

Article Multidisciplinary Sciences

Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)

Ikuo Kimura et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biotechnology & Applied Microbiology

Moving pictures of the human microbiome

J. Gregory Caporaso et al.

GENOME BIOLOGY (2011)

Article Microbiology

Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy

Anna Engelbrektson et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2009)

Article Gastroenterology & Hepatology

Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response

Yan-Dong Wang et al.

HEPATOLOGY (2008)

Article Hematology

Farnesoid X receptor ligands inhibit vascular smooth muscle cell inflammation and migration

Yoyo T. Y. Li et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Review Cardiac & Cardiovascular Systems

The importance of the gastrointestinal system in the pathogenesis of heart failure

A Krack et al.

EUROPEAN HEART JOURNAL (2005)

Article Infectious Diseases

Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy

SF Plummer et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)

Article Multidisciplinary Sciences

Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes

NH Purcell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Review Pharmacology & Pharmacy

Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: Criteria, validation, strategies

LJ Lesko et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)